Position in MRK
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$36,550,838
+$5,611,872 QoQ
Shares Held
303,856
+3.4% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
2.98%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Arax Advisory Partners holds $77,931,464 across 17 Drug Manufacturers - General names. MRK ranks #1 (46.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
303,856 | $36,550,838 | |
| 2 | ABBV |
AbbVie Inc.
|
48,857 | $10,625,908 | |
| 3 | JNJ |
Johnson & Johnson
|
41,381 | $10,115,171 | |
| 4 | LLY |
ELI LILLY & Co
|
6,998 | $6,436,550 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
73,108 | $4,434,000 | |
| 6 | PFE |
Pfizer Inc
|
79,856 | $2,242,356 | |
| 7 | AMGN |
Amgen Inc
|
5,229 | $1,839,823 | |
| 8 | AZN |
Astrazeneca PLC
|
6,722 | $1,325,712 |
All Filings in MRK
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $36,550,838 | 303,856 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $30,938,966 | 293,929 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,030,057 | 429,287 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $22,413,520 | 283,142 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1,100,546 | 12,261 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $655,075 | 6,585 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $727,351 | 6,405 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $761,121 | 6,148 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $694,452 | 5,263 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $549,132 | 5,037 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $510,219 | 4,956 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $584,911 | 5,069 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $530,566 | 4,987 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $555,304 | 5,005 | Shares | Sole | 2023-02-24 | |
| 2022-09-30 | $393,568 | 4,570 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $456,305 | 5,005 | Shares | Sole | 2022-08-22 | |
| 2022-03-31 | $359,050 | 4,376 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $371,780 | 4,851 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $364,058 | 4,847 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $295,681 | 3,802 | Shares | Sole | 2021-08-02 | |
| 2020-12-31 | $247,741 | 3,174 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $242,676 | 3,066 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $348,649 | 4,725 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $346,523 | 4,720 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||